These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 15611295)
1. Role of Dok-1 and Dok-2 in leukemia suppression. Niki M; Di Cristofano A; Zhao M; Honda H; Hirai H; Van Aelst L; Cordon-Cardo C; Pandolfi PP J Exp Med; 2004 Dec; 200(12):1689-95. PubMed ID: 15611295 [TBL] [Abstract][Full Text] [Related]
2. High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C/EBPalpha-driven myeloid differentiation. Chang JS; Santhanam R; Trotta R; Neviani P; Eiring AM; Briercheck E; Ronchetti M; Roy DC; Calabretta B; Caligiuri MA; Perrotti D Blood; 2007 Aug; 110(3):994-1003. PubMed ID: 17475908 [TBL] [Abstract][Full Text] [Related]
3. Haploinsufficiency and acquired loss of Bcl11b and H2AX induces blast crisis of chronic myelogenous leukemia in a transgenic mouse model. Nagamachi A; Yamasaki N; Miyazaki K; Oda H; Miyazaki M; Honda Z; Kominami R; Inaba T; Honda H Cancer Sci; 2009 Jul; 100(7):1219-26. PubMed ID: 19432895 [TBL] [Abstract][Full Text] [Related]
4. Role of the rasGAP-associated docking protein p62(dok) in negative regulation of B cell receptor-mediated signaling. Yamanashi Y; Tamura T; Kanamori T; Yamane H; Nariuchi H; Yamamoto T; Baltimore D Genes Dev; 2000 Jan; 14(1):11-6. PubMed ID: 10640270 [TBL] [Abstract][Full Text] [Related]
5. Disruption of the estrogen receptor beta gene in mice causes myeloproliferative disease resembling chronic myeloid leukemia with lymphoid blast crisis. Shim GJ; Wang L; Andersson S; Nagy N; Kis LL; Zhang Q; Mäkelä S; Warner M; Gustafsson JA Proc Natl Acad Sci U S A; 2003 May; 100(11):6694-9. PubMed ID: 12740446 [TBL] [Abstract][Full Text] [Related]
6. Suppression of E-protein activity interferes with the development of BCR-ABL-mediated myeloproliferative disease. Ko J; Patel N; Ikawa T; Kawamoto H; Frank O; Rivera RR; Van Etten RA; Murre C Proc Natl Acad Sci U S A; 2008 Sep; 105(35):12967-72. PubMed ID: 18725623 [TBL] [Abstract][Full Text] [Related]
7. Identification of DOK genes as lung tumor suppressors. Berger AH; Niki M; Morotti A; Taylor BS; Socci ND; Viale A; Brennan C; Szoke J; Motoi N; Rothman PB; Teruya-Feldstein J; Gerald WL; Ladanyi M; Pandolfi PP Nat Genet; 2010 Mar; 42(3):216-23. PubMed ID: 20139980 [TBL] [Abstract][Full Text] [Related]
8. Plasma exosomal DOK3 reflects immunological states in lung tumor and predicts prognosis of gefitinib treatment. Ochiai R; Hayashi K; Yamamoto H; Fujii R; Saichi N; Shinchi H; Ishida T; Honda T; Shimizu T; Matsutani N; Seki N; Kawamura M; Ueda K Cancer Sci; 2022 Nov; 113(11):3960-3971. PubMed ID: 36028467 [TBL] [Abstract][Full Text] [Related]
9. Deciphering the Molecular Mechanism Underlying African Animal Trypanosomiasis by Means of the 1000 Bull Genomes Project Genomic Dataset. Rajavel A; Klees S; Hui Y; Schmitt AO; Gültas M Biology (Basel); 2022 May; 11(5):. PubMed ID: 35625470 [TBL] [Abstract][Full Text] [Related]
10. DOK2 Has Prognostic and Immunologic Significance in Adults With Acute Myeloid Leukemia: A Novel Immune-Related Therapeutic Target. Xu J; Dong X; Wang R; Chen B Front Med (Lausanne); 2022; 9():842383. PubMed ID: 35321466 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of DOK family genes expression, immune characteristics, and drug sensitivity in human tumors. Guan Y; Li M; Qiu Z; Xu J; Zhang Y; Hu N; Zhang X; Guo W; Yuan J; Shi Q; Wang W J Adv Res; 2022 Feb; 36():73-87. PubMed ID: 35127166 [TBL] [Abstract][Full Text] [Related]
12. Hsa_Circ_0001947/MiR-661/DOK7 Axis Restrains Non-Small Cell Lung Cancer Development. Bao Y; Yu Y; Hong B; Lin Z; Qi G; Zhou J; Liu K; Zhang X J Microbiol Biotechnol; 2021 Nov; 31(11):1508-1518. PubMed ID: 34528912 [TBL] [Abstract][Full Text] [Related]
13. Introduction to DOK2 and its potential role in cancer. Sun P; Li R; Meng Y; Xi S; Wang Q; Yang X; Peng X; Cai J Physiol Res; 2021 Nov; 70(5):671-685. PubMed ID: 34505522 [TBL] [Abstract][Full Text] [Related]
14. Compound haploinsufficiency of Dok2 and Dusp4 promotes lung tumorigenesis. Chen M; Zhang J; Berger AH; Diolombi MS; Ng C; Fung J; Bronson RT; Castillo-Martin M; Thin TH; Cordon-Cardo C; Plevin R; Pandolfi PP J Clin Invest; 2019 Jan; 129(1):215-222. PubMed ID: 30475228 [TBL] [Abstract][Full Text] [Related]
15. Purification of zebrafish erythrocytes as a means of identifying a novel regulator of haematopoiesis. Kulkeaw K; Inoue T; Ishitani T; Nakanishi Y; Zon LI; Sugiyama D Br J Haematol; 2018 Feb; 180(3):420-431. PubMed ID: 29265183 [TBL] [Abstract][Full Text] [Related]
16. Turning the tide in myelodysplastic/myeloproliferative neoplasms. Deininger MWN; Tyner JW; Solary E Nat Rev Cancer; 2017 Jun; 17(7):425-440. PubMed ID: 28642604 [TBL] [Abstract][Full Text] [Related]
17. Dok-1 and Dok-2 Are Required To Maintain Herpes Simplex Virus 1-Specific CD8 Lahmidi S; Yousefi M; Dridi S; Duplay P; Pearson A J Virol; 2017 Aug; 91(15):. PubMed ID: 28490594 [TBL] [Abstract][Full Text] [Related]
18. Effects of expressing human T-cell leukemia virus type 1 (HTLV-I) oncoprotein Tax on DOK1, DOK2 and DOK3 gene expression in mice. Ohsugi T J Vet Med Sci; 2017 May; 79(5):935-938. PubMed ID: 28302940 [TBL] [Abstract][Full Text] [Related]
19. The non-genomic loss of function of tumor suppressors: an essential role in the pathogenesis of chronic myeloid leukemia chronic phase. Crivellaro S; Carrà G; Panuzzo C; Taulli R; Guerrasio A; Saglio G; Morotti A BMC Cancer; 2016 May; 16():314. PubMed ID: 27184141 [TBL] [Abstract][Full Text] [Related]
20. Dok-1 negatively regulates platelet integrin αIIbβ3 outside-in signalling and inhibits thrombosis in mice. Niki M; Nayak MK; Jin H; Bhasin N; Plow EF; Pandolfi PP; Rothman PB; Chauhan AK; Lentz SR Thromb Haemost; 2016 May; 115(5):969-78. PubMed ID: 26790499 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]